Elmadani M - Search Results

1

A synthetic lethal dependency on casein kinase 2 in response to replication-perturbing therapeutics in RB1-deficient cancer cells.

Bulanova D, Akimov Y, Senkowski W, Oikkonen J, Gall-Mas L, Timonen S, Elmadani M, Hynninen J, Hautaniemi S, Aittokallio T, Wennerberg K. Bulanova D, et al. Among authors: elmadani m. Sci Adv. 2024 May 24;10(21):eadj1564. doi: 10.1126/sciadv.adj1564. Epub 2024 May 23. Sci Adv. 2024. PMID: 38781347 Free PMC article.

2

Dasatinib targets c-Src kinase in cardiotoxicity.

Elmadani M, Raatikainen S, Mattila O, Alakoski T, Piuhola J, Åström P, Tenhunen O, Magga J, Kerkelä R. Elmadani M, et al. Toxicol Rep. 2023 Apr 25;10:521-528. doi: 10.1016/j.toxrep.2023.04.013. eCollection 2023. Toxicol Rep. 2023. PMID: 37152411 Free PMC article.

3

Genetic variants of ALR (-106C → T /-12C → G) and serum PKC-δ are associated with peripheral neuropathy in Egyptian diabetic patients with impaired handwriting.

Fattah SA, Elmadani M, Abo-Elmatty DM, Awadallah M, Mehanna ET. Fattah SA, et al. Among authors: elmadani m. J Diabetes Metab Disord. 2022 Feb 24;21(1):557-565. doi: 10.1007/s40200-022-01008-0. eCollection 2022 Jun. J Diabetes Metab Disord. 2022. PMID: 35673475 Free PMC article.

4

Prevalence of cryptosporidiosis among children with diarrhoea under five years admitted to Kosti teaching hospital, Kosti City, Sudan.

Tamomh AG, Agena AM, Elamin E, Suliman MA, Elmadani M, Omara AB, Musa SA. Tamomh AG, et al. Among authors: elmadani m. BMC Infect Dis. 2021 Apr 14;21(1):349. doi: 10.1186/s12879-021-06047-1. BMC Infect Dis. 2021. PMID: 33853528 Free PMC article.

5

Novel Screening Method Identifies PI3Kα, mTOR, and IGF1R as Key Kinases Regulating Cardiomyocyte Survival.

Elmadani M, Khan S, Tenhunen O, Magga J, Aittokallio T, Wennerberg K, Kerkelä R. Elmadani M, et al. J Am Heart Assoc. 2019 Nov 5;8(21):e013018. doi: 10.1161/JAHA.119.013018. Epub 2019 Oct 16. J Am Heart Assoc. 2019. PMID: 31617439 Free PMC article.

6

Clinical efficacy of the optimal biological dose in early-phase trials of anti-cancer targeted therapies.

Corbaux P, El-Madani M, Tod M, Péron J, Maillet D, Lopez J, Freyer G, You B. Corbaux P, et al. Eur J Cancer. 2019 Oct;120:40-46. doi: 10.1016/j.ejca.2019.08.002. Epub 2019 Aug 31. Eur J Cancer. 2019. PMID: 31479946 Review.

7

EVESOR, a model-based, multiparameter, Phase I trial to optimize the benefit/toxicity ratio of everolimus and sorafenib.

El-Madani M, Colomban O, Tod M, Maillet D, Peron J, Rodriguez-Lafrasse C, Badary OA, Valette PJ, Lefort T, Cassier P, El-Shenawy SM, El-Demerdash E, Hommel-Fontaine J, Guitton J, Gagnieu MC, Ibrahim BM, Barrois C, Freyer G, You B. El-Madani M, et al. Future Oncol. 2017 Apr;13(8):679-693. doi: 10.2217/fon-2016-0357. Epub 2017 Jan 12. Future Oncol. 2017. PMID: 28076966 Clinical Trial.

8

Multiparameter Phase I trials: a tool for model-based development of targeted agent combinations--example of EVESOR trial.

El-Madani M, Hénin E, Lefort T, Tod M, Freyer G, Cassier P, Valette PJ, Rodriguez-Lafrasse C, Berger F, Guitton J, Lachuer J, Slimane K, Barrois C, You B. El-Madani M, et al. Future Oncol. 2015;11(10):1511-8. doi: 10.2217/fon.15.49. Future Oncol. 2015. PMID: 25963428 Clinical Trial.

9

Investigating student interactions with tutorial dialogues in EER-Tutor.

Elmadani M, Mitrovic A, Weerasinghe A, Neshatian K. Elmadani M, et al. Res Pract Technol Enhanc Learn. 2015;10(1):16. doi: 10.1186/s41039-015-0013-1. Epub 2015 Jul 28. Res Pract Technol Enhanc Learn. 2015. PMID: 30613225 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page